Skip to main content

Full discussion of the HTA results

  • Chapter
  • 1205 Accesses

Abstract

It was the task of the present HTA to evaluate, within the PEK context, the efficacy, appropriateness (in terms of demand and safety) and economy of homeopathy. For this purpose the situation in Switzerland had to be assessed and reflected as realistically as possible.

Keywords

  • False Negative Result
  • Full Discussion
  • National Health Insurance Scheme
  • Complementary Alternative Medicine
  • Anthroposophic Medicine

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-642-20638-2_13
  • Chapter length: 12 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   84.99
Price excludes VAT (USA)
  • ISBN: 978-3-642-20638-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   109.99
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alderson P, Green S, Higgins J. Cochrane Reviewers’ Handbook. Handbook 4.2.1. [updated December 2003]. Chichester: John Wiley & Sons Ltd, 2004

    Google Scholar 

  • Altman DG, Bland JM. Absence of evidence is not evidence of absence. British Medical Journal 1995;311:485

    PubMed  CAS  Google Scholar 

  • Chaufferin G. Improving the evaluation of homeopathy: economic considerations and impact on health. British Homeopathic Journal 2000;89(1):27–30

    CrossRef  Google Scholar 

  • Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy (A meta-analysis of clinical trials). European Journal of Clinical Pharmacology 2000;56:27–33

    PubMed  CrossRef  CAS  Google Scholar 

  • Glanville J, Sowden A. Identification of the need for a review. In: Khan K, ter Riet G, Glanville J, Sowden A, Kleijnen J (editors). Undertaking Systematic Reviews of Research on Effectiveness. CRD Report Number 4 (2nd Edition), York, 2001

    Google Scholar 

  • Güthlin C, Walach H. Prospektive Dokumentationsstudie in der niedergelassenen Praxis – ein Erprobungsverfahren zur Akupunktur und Homöopathie. Erfahrungsheilkunde 2001;(50):186–94

    CrossRef  Google Scholar 

  • Güthlin C, Lange O, Walach H. Measuring the effects of acupuncture and homeopathy in general practice: An uncontrolled prospective documentation approach. BMC Public Health 2004;4(6).

    PubMed  CrossRef  Google Scholar 

  • Heusser P. Komplementärmedizin in der Grundversicherung: Verteuert sie die Gesundheitskosten? Schweizerische Zeitschrift für GanzheitsMedizin 1999;11 :4–9

    Google Scholar 

  • Jenny S, Simon M, Meier B. Haltung der Bevölkerung gegenüber der Komplementärmedizin Schweizerische Zeitschrift für GanzheitsMedizin 2002;14:340–7

    Google Scholar 

  • Kienle G. Arzneimittelsicherheit und Gesellschaft. Eine kritische Untersuchung. Stuttgart New York: Schattauer, 1974

    Google Scholar 

  • Kienle GS, Kiene H. Können aus der Studie „Komplementärmedizin in der Krankenversicherung“ wissenschaftlich tragfähige Schlüsse gezogen werden? Forschende Komplementärmedizin 1999;6(5):262–70

    PubMed  CrossRef  CAS  Google Scholar 

  • Kienle GS, Kiene H, Albonico HU. Anthroposophic Medicine. Effectiveness, utility, costs, safety. Stuttgart New York: Schattauer 2006b

    Google Scholar 

  • Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy. British Medical Journal 1991;302(6772):316–23.

    PubMed  CrossRef  CAS  Google Scholar 

  • Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350(9081):834–43.

    PubMed  CrossRef  CAS  Google Scholar 

  • Linde K, Melchart D: Randomized controlled trials of individual homeopathy: a state-of-the-art review. The Journal of Alternative and Complementary Medicine 1998;4(4):371–388

    PubMed  CrossRef  CAS  Google Scholar 

  • Lüdtke R, Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology. 2008; 61 (12):1197–1204.

    PubMed  CrossRef  Google Scholar 

  • Marstedt G, Moebus S. Gesundheitsberichterstattung des Bundes Heft 9: Inanspruchnahme alternativer Methoden in der Medizin. Berlin: Verlag Robert Koch Institut, 2002

    Google Scholar 

  • Mathie RT: The research ecidence base for homeopathy: a fresh assessment of the literature. Homeopathy 2003; 92(2):84–91

    PubMed  CrossRef  CAS  Google Scholar 

  • Niroomand F. Evidenzbasierte Medizin: Das Individuum bleibt auf der Strecke. Deutsches Ärzteblatt 2004; 101(26):1870–4

    Google Scholar 

  • Rutten AL, Stolper, CF. The 2005 meta-analysis of homeopathy: the importance of post-publication data. Homeopathy. 2008;97(4):169–77

    PubMed  CrossRef  CAS  Google Scholar 

  • Schüppel R. Kosten und Nutzen der Homöopathie - Ein echtes Schnäppchen? Der Hausarzt 2003;19:64

    Google Scholar 

  • Shang A, Huwiler-Muntener K, Nartey L et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366:726–732

    PubMed  CrossRef  Google Scholar 

  • SIGN 50 (Scottish Intercollegiate Guidelines Network). A guideline developer‘s handbook. Notes on the use of Methodology Checklist 2: Randomized Controlled Trials. 2005. available at: http://www.sign.ac.uk/guidelines/fulltext/50/notes2.html

  • Sommer JH, Burgi M, Theiss R. Inclusion of complementary medicine increases health costs. Focus on Alternative & Complementary Therapies 1999;4(4):183–4

    Google Scholar 

  • Taieb C, Myon E. The economic impact of homeopathic management: the french example. Value Health 2003; 6(3):373

    CrossRef  Google Scholar 

  • Trichard M, Chaufferin G, Nicoloyannis N. Pharmacoeconomic comparison between two drug stragegies of treatment of anxiety disorders: homeopathy and psychotropics (ISPOR Poster PMH23). Value in Health 2003; 6(3):350–1

    CrossRef  Google Scholar 

  • Walach H. Unspezifische Therapie-Effekte – Das Beispiel Homöopathie. Habilitationsschrift Psychologisches Institut, Albert-Ludwigs-Universität Freiburg, 1997

    Google Scholar 

  • Wegscheider K. Was sind faire Vergleiche zwischen Therapien? Zeitschrift für ärztliche Fortbildung und Qualität im Gesundheitswesen 2005;99(4–5):275–8

    PubMed  Google Scholar 

  • Wein C. Qualitätsaspekte klinischer Studien zur Homöopathie. Essen: KVC-Verlag, 2002

    Google Scholar 

  • World Medical Association, Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bulletin of the World Health Organization, 2001;79(4):373–4. available at: http://whqlibdoc.who.int/bulletin/2001/issue4/79(4)declaration.pdf

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bornhöft, G., v. Ammon, K., Righetti, M., Thuneysen, A., Matthiessen, P.F. (2011). Full discussion of the HTA results. In: Bornhöft, G., Matthiessen, P.F. (eds) Homeopathy in Healthcare – Effectiveness, Appropriateness, Safety, Costs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20638-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-20638-2_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-20637-5

  • Online ISBN: 978-3-642-20638-2

  • eBook Packages: MedicineMedicine (R0)